Lunai Bioworks Inc.

RENB · NASDAQ
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income-$178,007-$80,650-$39,684-$113,433
Dep. & Amort.$129$122$113$124
Deferred Tax$0$0$0$0
Stock-Based Comp.$3,313$4,673$3,535$5,491
Change in WC$5,860$8,812$4,305$1,415
Other Non-Cash$160,830$56,072$996-$2,599
Operating Cash Flow-$7,875-$10,971-$11,775-$15,732
Investing Activities
PP&E Inv.$0-$70-$30-$5
Net Acquisitions$0$66$0$0
Inv. Purchases-$500$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0-$1,256$0$0
Investing Cash Flow-$500-$1,260-$30-$5
Financing Activities
Debt Repay.$6,978$8,046-$1,122-$561
Stock Issued$2,376$3,000$4,012$4,676
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$971-$528$1,625$135
Financing Cash Flow$8,383$10,517$4,515$4,250
Forex Effect-$136$60-$8-$5
Net Chg. in Cash-$128-$1,654-$7,298-$11,492
Supplemental Information
Beg. Cash$220$1,874$9,172$20,664
End Cash$93$220$1,874$9,172
Free Cash Flow-$7,875-$11,042-$11,804-$15,737